The OHSU Knight Cancer Institute is an international leader in cancer research and personalized cancer treatment. With the mission of ending cancer as we know it, the Knight Cancer Institute continues to build its scientific and clinical leadership and cancer treatment resources. Every year, the institute treats about 6,000 patients and conducts about 1,400 research projects, including more than 400 clinical trials. Public support — including from the State of Oregon and private philanthropy — has provided crucial resources to advance its progress.
Building on Phil and Penny Knight’s initial $1 billion gift a decade ago, their record-breaking $2 billion commitment in 2025 accelerates the Knight Cancer Institute’s mission to end cancer. The institute is driving innovations in prevention, treatment and cures for future generations.
- Latest Stories
Promising new technique uses nanoparticles to detect pancreatic cancer
New cancer research tool predicts patient survival at single-cell resolution
OHSU first in Pacific Northwest to perform revolutionary new cancer treatment procedure
New imaging tools help cancer researchers see inside living cells
- OHSU Knight Cancer Institute: View and download multimedia from the OHSU Knight Cancer Institute
- Phil and Penny Knight's record-breaking $2 billion gift: View and download multimedia from the Knight’s generous donation to Give Cancer Hell.
- Knight Cancer Challenge: View and download multimedia related to the successful completion of the $1 billion cancer fundraising challenge.
- Knight Cancer Research Building: View and download multimedia related to the Knight Cancer Research Building.
- Knight Cancer Precision Biofabrication Hub: Precision engineering and innovative biofabrication tools to build complex models of cancer.